Cerenome CNSY
NASDAQ CNSY
$2.96 +0.02 (+0.68%)
As of: Sep 3, 2026 · 3:56 PM EDT

Cerenome (CNSY) Enterprise Value (2010 - 2026)

Analysis

Cerenome (CNSY) Enterprise Value (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 141.52 Bn 133.66 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.69 Bn 78.69 Bn 3.93 Bn
3 Argenx Se 64.63 Bn 59.45 Bn 1.37 Bn
4 Moderna 59.30 Bn 54.16 Bn 52.00 Mn
5 Revolution Medicines 44.41 Bn 44.41 Bn -
6 BeOne Medicines 40.45 Bn 35.35 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.29 Bn 31.98 Bn 992.69 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn -
9 Insmed 27.55 Bn 26.39 Bn 358.27 Mn
10 Cerenome 20.42 Mn 11.83 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 23.36 Mn
Mar 31, 2026 12.33 Mn
Dec 31, 2025 30.82 Mn
Sep 30, 2025 22.73 Mn
Jun 30, 2025 10.06 Mn
Mar 31, 2025 6.28 Mn
Dec 31, 2024 3.17 Mn
Sep 30, 2024 6.68 Mn
Jun 30, 2024 -49,789.25
Mar 31, 2024 4.11 Mn
Dec 31, 2023 -3.06 Mn
Sep 30, 2023 -6.68 Mn
Jun 30, 2023 -5.08 Mn
Mar 31, 2023 144.42 Mn
Dec 31, 2022 107.91 Mn
Sep 30, 2022 199.58 Mn
Jun 30, 2022 163.91 Mn
Mar 31, 2022 311.73 Mn
Dec 31, 2021 172.00 Mn
Sep 30, 2021 418.78 Mn